Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer
Clinical trial NCT07637513 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07637513
- Sponsor
- PrECOG, LLC.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-01
- Primary completion
- 2037-11-01
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.